Literature DB >> 18591369

A potential means of investigating the role of luteinizing hormone in the pathogenesis of Alzheimer disease.

James S Welsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591369      PMCID: PMC2442024          DOI: 10.3121/cmr.2008.791

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


× No keyword cloud information.
  4 in total

Review 1.  Evidence for the role of luteinizing hormone in Alzheimer disease.

Authors:  Kate M Webber; Gemma Casadesus; Richard L Bowen; George Perry; Mark A Smith
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2007-12       Impact factor: 2.895

2.  Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

Authors:  Miljenko V Pilepich; Kathryn Winter; Colleen A Lawton; Robert E Krisch; Harvey B Wolkov; Benjamin Movsas; Eugen B Hug; Sucha O Asbell; David Grignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

3.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

Review 4.  The contribution of luteinizing hormone to Alzheimer disease pathogenesis.

Authors:  Kate M Webber; George Perry; Mark A Smith; Gemma Casadesus
Journal:  Clin Med Res       Date:  2007-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.